Skip to content

Clinical trials

Hemophilia A trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Country / region: China Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20112
20122
20131
20142
20154
20165
20171
20186
20196
20205
202111
20228
20238
20248
20255
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting19
Unknown status14
Active, not recruiting10
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China11
Hangzhou Gensciences Biopharmaceutical Co., Ltd.8
Pfizer7
Bayer5
Hoffmann-La Roche5
Novo Nordisk A/S5
Sinocelltech Ltd.5
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.4
Genzyme, a Sanofi Company4
Staidson (Beijing) Biopharmaceuticals Co., Ltd4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A86
Hemophilia B12
Hemostatic Disorders3
Anemia, Aplastic2
Blood Coagulation Disorders2
Blood Coagulation Disorders, Inherited2
Coagulation Protein Disorders2
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Hematologic Diseases2

Trials

Showing 76 to 86 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.